Datavant Announces Strategic Partnership with Seqsterto Optimize its RWD Offering to Life Science Companies

Datavant Announces Strategic Partnership with Seqsterto Optimize its RWD Offering to Life Science Companies

In this partnership, Datavant's privacy-preserving linking technology will be integrated within Seqster's patient-centric interoperability platform.

FREMONT, CA: Datavant, the leader in helping healthcare organizations connect their data safely, announced a strategic partnership with Seqster, the award-winning SaaS-based healthcare technology company enabling patient-centric interoperability. For the first time, real-time medical records, wearables, and genomics data could be connected with other health data sources to create a live 360° view of the patient.

"Integrating real-world data into clinical trials enables sponsors to accelerate the clinical and commercial development process, increasing the speed of therapies to market. Seqster has an innovative solution that utilizes patient data already captured in EHRs to fill important data gaps," said Travis May, Chief Executive Officer at Datavant. "We are living through a fundamental transformation in the use of RWD, and we firmly believe that the effective use of real-world data can help better understand the safety and efficacy of drugs that are brought to market."

Seqster's first-of-its-kind platform enables life science companies and CROs to automatically retrieve patient data directly from a patients' EHR record for the clinical trial process. With this new partnership, Seqster will also have the ability to match real-world data from Datavant's open data ecosystem to their existing patient-level data collected through the Seqster platform. The new combined solution gives life sciences customers an off-the-shelf system to seamlessly process and analyze a patient's longitudinal health journey, leading to a better understanding of patient outcomes, therapy efficacy, and value-based healthcare.

"We are excited to enter into this partnership to continue providing innovative ways for life sciences companies to better understand the patients participating in their trials, said Ardy Arianpour, Chief Executive Officer & Co-Founder at Seqster. "The combination of Seqster's FDA-compliant platform and Datavant's privacy-protecting linking technology provides a vital data super-highway that is secure, private, and readily accessible for pharmaceutical companies and the broader healthcare ecosystem."